Scot-Tussin Expectorant SF Cough

Product NDC: 0372-0006
11-digit product format: 003720006
Labeler code: 0372
Product ID: 0372-0006_a02a5ca8-8c0d-4be5-92b1-5271d555f252
Type: HUMAN OTC DRUG
Nonproprietary name: Guaifenesin
Dosage form: LIQUID
Route: ORAL
Labeler: SCOT-TUSSIN Pharmacal Co., Inc.
Application: part341
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 1974-07-01
Marketing end: 0000-00-00
Substance: GUAIFENESIN
Active strength: 100 mg/5mL
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	0372-0006		I	Inactivated by FDA		2026-08-11
excluded package	package	0372-0006	0372-0006-04	I	Inactivated by FDA		2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 42 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0372-0006-04	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0372-0006-04	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0372-0006-04	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0372-0006-04	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0372-0006-04	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0372-0006-04	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0372-0006-04	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0372-0006-04	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0372-0006-04	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0372-0006-04	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0372-0006-04	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0372-0006-04	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	0372-0006-04	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	0372-0006-04	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	0372-0006-04	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	0372-0006-04	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	0372-0006-04	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	0372-0006-04	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	0372-0006-04	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	0372-0006-04	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	0372-0006-04	`9bebd1f3094a…`	`5416666fcb17…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c6f86816-7da6-43ea-8c25-ac9758311cc5	Product name	1	20220118
252e11b6-1a9a-4283-a242-df2c129c496d	Product name	3	20170717
4fe95224-f543-4dbb-9445-8cca122b48c8	Product name	1	20150609
e8718272-64cb-4436-969b-176c3067c8f4	Product name	1	20150609
106ff02a-57e1-4c4c-a307-fd582ff4e311	Product name	1	20150212

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
0372-0006-04	2020-01-31	C162847	48780-1	9d75b9d0-ebb1-f424-e053-dadaa90a57ce	Scot-Tussin Expectorant SF Cough

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0372-0006-04	Scot-Tussin Expectorant SF Cough	118 mL in 1 BOTTLE	LIQUID	118		4

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0372-0006-04	ML - Milliliter	0372-0006	6491e72b-a51c-4218-b48f-f3dd1e1783ab	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
GUAIFENESIN	ACTIVE INGREDIENT	495W7451VQ	SCOT-TUSSIN EXPECTORANT SF COUGH (GUAIFENESIN) LIQUID [SCOT-TUSSIN PHARMACAL CO., INC.]	4
GUAIFENESIN	ACTIVE MOIETY	495W7451VQ	SCOT-TUSSIN EXPECTORANT SF COUGH (GUAIFENESIN) LIQUID [SCOT-TUSSIN PHARMACAL CO., INC.]	4
ASPARTAME	INACTIVE INGREDIENT	Z0H242BBR1	SCOT-TUSSIN EXPECTORANT SF COUGH (GUAIFENESIN) LIQUID [SCOT-TUSSIN PHARMACAL CO., INC.]	4
BENZOIC ACID	INACTIVE INGREDIENT	8SKN0B0MIM	SCOT-TUSSIN EXPECTORANT SF COUGH (GUAIFENESIN) LIQUID [SCOT-TUSSIN PHARMACAL CO., INC.]	4
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	SCOT-TUSSIN EXPECTORANT SF COUGH (GUAIFENESIN) LIQUID [SCOT-TUSSIN PHARMACAL CO., INC.]	4
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	SCOT-TUSSIN EXPECTORANT SF COUGH (GUAIFENESIN) LIQUID [SCOT-TUSSIN PHARMACAL CO., INC.]	4
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	SCOT-TUSSIN EXPECTORANT SF COUGH (GUAIFENESIN) LIQUID [SCOT-TUSSIN PHARMACAL CO., INC.]	4
MENTHOL	INACTIVE INGREDIENT	L7T10EIP3A	SCOT-TUSSIN EXPECTORANT SF COUGH (GUAIFENESIN) LIQUID [SCOT-TUSSIN PHARMACAL CO., INC.]	4
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	SCOT-TUSSIN EXPECTORANT SF COUGH (GUAIFENESIN) LIQUID [SCOT-TUSSIN PHARMACAL CO., INC.]	4
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	SCOT-TUSSIN EXPECTORANT SF COUGH (GUAIFENESIN) LIQUID [SCOT-TUSSIN PHARMACAL CO., INC.]	4
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	SCOT-TUSSIN EXPECTORANT SF COUGH (GUAIFENESIN) LIQUID [SCOT-TUSSIN PHARMACAL CO., INC.]	4
WATER	INACTIVE INGREDIENT	059QF0KO0R	SCOT-TUSSIN EXPECTORANT SF COUGH (GUAIFENESIN) LIQUID [SCOT-TUSSIN PHARMACAL CO., INC.]	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0372-0006	SCOT-TUSSIN EXPECTORANT SF COUGH (GUAIFENESIN) LIQUID [SCOT-TUSSIN PHARMACAL CO., INC.]	4	Legacy NDC, 1 package rows	20130125_2cd6ab31-1fae-4737-b6af-50586323b751.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
495W7451VQ	GUAIFENESIN	93-14-1	GUAIFENESIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310604	guaiFENesin 100 MG in 5 mL Oral Solution	PSN	2cd6ab31-1fae-4737-b6af-50586323b751	4
213158	Scot-Tussin 100 MG in 5 mL Oral Solution	PSN	2cd6ab31-1fae-4737-b6af-50586323b751	4
213158	guaifenesin 20 MG/ML Oral Solution [Scot-Tussin]	SBD	2cd6ab31-1fae-4737-b6af-50586323b751	4
310604	guaifenesin 20 MG/ML Oral Solution	SCD	2cd6ab31-1fae-4737-b6af-50586323b751	4
310604	guaifenesin 100 MG per 5 ML Oral Solution	SY	2cd6ab31-1fae-4737-b6af-50586323b751	4
310604	guaifenesin 100 MG per 5 ML Oral Syrup	SY	2cd6ab31-1fae-4737-b6af-50586323b751	4
310604	guaifenesin 200 MG per 10 ML Oral Solution	SY	2cd6ab31-1fae-4737-b6af-50586323b751	4
310604	guaifenesin 300 MG per 15 ML Oral Solution	SY	2cd6ab31-1fae-4737-b6af-50586323b751	4
310604	guaifenesin 400 MG per 20 ML Oral Solution	SY	2cd6ab31-1fae-4737-b6af-50586323b751	4
213158	Scot-Tussin 100 MG per 5 ML Oral Solution	SY	2cd6ab31-1fae-4737-b6af-50586323b751	4
213158	Scot-Tussin 20 MG/ML Oral Solution	SY	2cd6ab31-1fae-4737-b6af-50586323b751	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
0372-0006-04	00372000604	118 mL in 1 BOTTLE	118 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Scot-Tussin Expectorant SF Cough	SCOT-TUSSIN Pharmacal Co., Inc.	2013-01-29	HUMAN OTC DRUG LABEL	4